HTT and Parkinson disease: Examples include the protection of paroxetine against dyskinesia in Huntingtin mutant mice and nigrostriatal neurodegeneration in Parkinson’s disease mouse model [31, 32] and the venlafaxine-mediated improvement of cognitive impairment and depressive behavior in multiple sclerosis mouse model [33].